HomeResearch & Knowledgeback to HomeStrategyback to Research & KnowledgeSandoz (B): The art of staying true to your missionback to Strategy

Case Study

Sandoz (B): The art of staying true to your mission

By Jim Pulcrano, Charan Singh, Zita Falk, Franciska Darmer and Barbara Schmidt-Ley

10 pages

September 2025

Order this case study

Reference: IMD-2670

This case series explores Sandoz’s spin off from Novartis, which was finalized on 4 October 2023. Case B looks at Sandoz once it has become independent. The hard work of figuring out the best way to spin off is done, a new strategy created, and some difficult choices made. But now how will CEO Richard Saynor and his leadership team ensure that Sandoz is fit for purpose?

Learning Objective

Understand the impact of the founding decisions.
Explore whether the spin-off choice was correct.
Be able to evaluate whether the chosen strategy decisions fit with the new organization.

Keywords

Strategy, Leadership, Global Business, Generic Drug, Spin-off, Healthcare, Life Science, Board Conflict, Chief Executive Officer, Good Health, Well-being, Reduced Inequalities

Settings

World/global, Switzerland
Sandoz, Healthcare, Pharmaceuticals
2022-2024

Type

Field Research

Available Languages

English

Related material

Teaching note

IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

This case study is part of a series

Sandoz (A): Breaking free to stand alone
Sandoz (B): The art of staying true to your mission

This case study is part of a series

Sandoz (A): Breaking free to stand alone
Sandoz (B): The art of staying true to your mission

Sandoz (A): Breaking free to stand alone

By Jim Pulcrano Charan Singh Zita Falk Franciska Darmer and Barbara Schmidt-Ley
Case reference: IMD-2669 ©2025

Summary

This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) rum...

Reference IMD-2669

Organization Sandoz

Industry Healthcare, Pharmaceuticals

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Strategy

Leadership

Global Business

Browse all topics

Sandoz (B): The art of staying true to your mission

By Jim Pulcrano Charan Singh Zita Falk Franciska Darmer and Barbara Schmidt-Ley
Case reference: IMD-2670 ©2025

Summary

This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case B looks at Sandoz once it has become indepen...

Reference IMD-2670

Organization Sandoz

Industry Healthcare, Pharmaceuticals

Available Languages English

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Related topics

Strategy

Leadership

Global Business

Browse all topics

Keep reading

Article

AI adoption is not a technology problem. It’s a leadership one

Businesses are adopting artificial intelligence at pace, and spending heavily to do so. Big Tech alone plans to invest more than US$660 billion (S$844 billion) in 2026. But for most companies, spending is running ahead of visible returns. A flood ...

Artificial Intelligence Leadership

By Amit M. Joshi

in The Straits Times

24 April 2026

Article

Is Tim Cook leaving Apple with an AI headache?

To some, Apple is starting to look like a company on the back foot. The appointment of Mr John Ternus, a long-time hardware chief, to CEO only sharpens the question of whether the US$4 trillion (S$5 trillion) company can keep pace in artificial in...

Innovation Strategy

By Howard H. Yu

in The Straits Times

23 April 2026